Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Lymphoma, Myeloma & Leukemia|September 18, 2017
Peripheral Blood Lymphocyte-to-Monocyte Ratio at Relapse Predicts Outcome for Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in the Rituximab EraDaisuke Katoh, Yotaro Ochi, Tomohiro Yabushita, et al.British Journal of Haematology|November 15, 2023
Sequential cellular and humoral responses after repetitive COVID-19 vaccination in patients treated with anti-CD20 antibodiesMasashi Nishikubo, Yoshimitsu Shimomura, Ryusuke Yamamoto, et al.Ejhaem|August 19, 2024
Complete detection of FR1 to FR3 primer-based PCR patterns of immunoglobulin heavy chain rearrangement in the BIOMED-2 protocol is associated with poor prognosis in patients with diffuse large B-cell lymphomaTomohiro Yabushita, Yoshimitsu Shimomura, Hayato Maruoka, et al.International Journal of Hematology|July 19, 2023
Efficacy of letermovir in HLA-haploidentical hematopoietic transplantation with posttransplant cyclophosphamideDaishi Nakagawa, Yoshimitsu Shimomura, Satoshi Mitsuyuki, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 28, 2022
Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in allogeneic hematopoietic stem cell transplant recipients: An observational studyMasashi Nishikubo, Yoshimitsu Shimomura, Hayato Maruoka, et al.European Journal of Haematology|March 25, 2023
Trajectories of the SARS-CoV-2 RNA load in patients with hematological malignancySatoshi Mitsuyuki, Masashi Nishikubo, Yoshimitsu Shimomura, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 4, 2023
[Manufacturing results of tisagenlecleucel for acute lymphoblastic leukemia: a survey by the CAR-T cell therapy taskforce of the Japan Society of Transfusion Medicine and Cell Therapy]Tomoyasu Jo, Tomoko Henzan, Daisuke Tomizawa, et al.Blood Neoplasia|June 23, 2025
Low platelet counts and low CD4/CD8 ratios at apheresis increase the risk of CAR T-cell manufacturing failure in myelomaTomoyasu Jo, Kyoko Yoshihara, Masaki Ri, et al.British Journal of Haematology|April 25, 2023
Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in JapanTomoyasu Jo, Satoshi Yoshihara, Yoshiki Okuyama, et al.Pageof 2